|
Market Cap (18-May) $1,025,901,888 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (5-May) 71,471,994 (10.35%) (8th) |
|
52w High $2.78 |
52w Low $0.93 |
P/E 70.92 |
EPS 0.01 |
PNV released this announcement to the ASX on 13 November 2020, 12:51. The announcement is marked as price sensitive, and is 6 page(s) in length and 241.23kb in size.
You can view all announcements from PNV and see how they appear on a price chart on the announcements page.
At the date of this announcement, PNV was 4.680% short sold according to ASIC data. It was ranked the 37th most shorted stock on the ASX. It is now ranked as the 8th most shorted stock on the ASX with 10.346% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PNV | |
|---|---|
| Appendix 3Y - Robyn Elliott | 30 June 2023, 10:41 |
| Director Share Purchase - David Williams | 8 June 2023, 15:14 |
| Director Share Purchase - David Williams | 8 June 2023, 8:19 |
| Chairman, Managing Director & SVP of Sales US - AGM address | 13 November 2020, 12:51 |
| USA FDA approves Pivotal Trial IDE | 13 November 2020, 10:30 |
| PolyNovo enters Greece - Distributor Appointment | 2 November 2020, 9:45 |
| Taiwan FDA Approval for PolyNovo | 28 October 2020, 9:11 |
You must be logged in to post a reply.
PolyNovo 